Evidence map›Paper›PMID 25217521›Full record

ArticleCancer research2014

Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography.

Shanice V Hudson, Justin S Huang, Wenyuan Yin, Sabrin Albeituni, Jamie Rush, Anil Khanal, Jun Yan, Brian P Ceresa, Hermann B Frieboes, Lacey R McNally

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 71 citations in OpenAlex.

  1. Assessment of Breast Tumors Using Multispectral Optoacoustic Tomography in a Surgical Setting.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. A HNature communications · 2021
    Article
  9. Article
  10. Tailor-Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  11. Review
  12. Photoacoustic Tomography Opening New Paradigms in Biomedical Imaging.Advances in experimental medicine and biology · 2021
    Article
  13. Review
  14. Dual-comb photoacoustic spectroscopy.Nature communications · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Shanice V HudsonDepartment of Medicine, University of Louisville, Kentucky.
Justin S HuangDepartment of Medicine, University of Louisville, Kentucky.
Wenyuan YinDepartment of Medicine, University of Louisville, Kentucky.
Sabrin AlbeituniDepartment of Medicine, University of Louisville, Kentucky.
Jamie RushDepartment of Pharmacology and Toxicology, University of Louisville, Kentucky.
Anil KhanalDepartment of Medicine, University of Louisville, Kentucky.
Jun YanDepartment of Medicine, University of Louisville, Kentucky.
Brian P CeresaDepartment of Pharmacology and Toxicology, University of Louisville, Kentucky.
Hermann B FrieboesDepartment of Pharmacology and Toxicology, University of Louisville, Kentucky. Department of Bioengineering, University of Louisville, Kentucky.
Lacey R McNallyDepartment of Medicine, University of Louisville, Kentucky. Department of Pharmacology and Toxicology, University of Louisville, Kentucky. lrmcna01@louisville.edu.
University of Louisville · US

Funding

Regulation of EGFR Signaling by the Endocytic PathwayR01GM092874 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CERESA, BRIAN P. · 2010 to 2013
$883k
KiSS1 treatment of pancreatic adenocarcinomaR00CA139050 · NCI · UNIVERSITY OF LOUISVILLE · PI MCNALLY, LACEY R · 2011 to 2013
$710k
KiSS1 treatment of pancreatic adenocarcinomaK99CA139050 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MCNALLY, LACEY R · 2009 to 2010
$180k
NCI NIH HHS CA139050NCI NIH HHS K99 CA139050NCI NIH HHS R00 CA139050NIGMS NIH HHS GM092874NIGMS NIH HHS R01 GM092874
6 · The paper itself

Abstract

Detection of orthotopic xenograft tumors is difficult due to poor spatial resolution and reduced image fidelity with traditional optical imaging modalities. In particular, light scattering and attenuation in tissue at depths beyond subcutaneous implantation hinder adequate visualization. We evaluate the use of multispectral optoacoustic tomography (MSOT) to detect upregulated epidermal growth factor (EGF) receptor in orthotopic pancreatic xenografts using a near-infrared EGF-conjugated CF-750 fluorescent probe. MSOT is based on the photoacoustic effect and thus not limited by photon scattering, resulting in high-resolution tomographic images. Pancreatic tumor-bearing mice with luciferase-transduced S2VP10L tumors were intravenously injected with EGF-750 probe before MSOT imaging. We characterized probe specificity and bioactivity via immunoblotting, immunocytochemistry, and flow cytometric analysis. In vitro data along with optical bioluminescence/fluorescence imaging were used to validate acquired MSOT in vivo images of probe biodistribution. Indocyanine green dye was used as a nonspecific control to define specificity of EGF-probe accumulation. Maximum accumulation occurred at 6 hours postinjection, demonstrating specific intratumoral probe uptake and minimal liver and kidney off-target accumulation. Optical bioluminescence and fluorescence imaging confirmed tumor-specific probe accumulation consistent with MSOT images. These studies demonstrate the utility of MSOT to obtain volumetric images of ligand probe biodistribution in vivo to detect orthotopic pancreatic tumor lesions through active targeting of the EGF receptor.

Indexed as

AnimalsErbB ReceptorsFluorescent DyesHumansMicePancreatic NeoplasmsPhotoacoustic TechniquesRadiographyTomographyXenograft Model Antitumor AssaysEGFR protein, humanErbB ReceptorsFluorescent Dyes

Identifiers

PMID25217521
PMCPMC4216771
OpenAlexW2101900188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.